Reshaping blood culture collection standard of care
Kurin® is a privately held, certified minority owned business dedicated to engineering better healthcare through innovative, cost-effective, clinician-approved technologies. Building on the successful invention, clinical adoption, and corporate acquisition of Curos™ disinfecting port protectors, Kurin is focusing its depth of experience in medical device engineering, marketing, sales and service, to tackle the persistent and costly fallout of false positive blood cultures. With agile development capabilities and intense customer focus, we have seen the Kurin Lock® initial specimen discard method quickly gain caregiver acceptance, sideline skin contaminants during blood culture collection, and become the blood culture collection standard of care in hospitals.
Curos™ is a registered trademark of 3M Corporation.